What's new
News
News Archive
Current News
07/02/2010
Evonik Increases Prices
Effective August 1, 2010, the business line Industrial Specialties of Evonik will increase prices in...

Degussa Tissue Additives: New Leaflet Softeners and Softener/Debonders for Tissue and Towelling


05/16/2007

New leaflet "Softeners and Softener/Debonders for Tissue and Towelling" now available

Degussa’s business line Goldschmidt Industrial Specialties has published a leaflet containing an overview on its softeners and softener/debonders for tissue and towelling applications.

The product range comprises tailor-made cationic formulations with high, medium and low debonding properties for different fiber types, cationic surface softeners with low debonding properties, non-ionic concentrates for surface smoothness enhancement, organomodified siloxane based products and organic cationc concentrates for further formulation or use in aqueous dispersions. Depending on the product type, the recommended uses cover wet end, spray on felt or converting applications, while most of the products are suitable for the production of customized blends.

The business line Goldschmidt Industrial Specialties is part of Degussa’s business unit Care & Surface Specialties. The product range includes mild surfactants, fatty acid derivatives, organomodified siloxanes as well as active oxygen compounds as detergent raw materials. Its outstanding core competence is its comprehensive knowledge of the processes of interfacial chemistry. On this basis, the business unit supplies its customers with tailor-made products and system solutions that are at the forefront of technology, for a variety of applications in the fast moving consumer goods markets.


Degussa - a wholly owned subsidiary of the RAG Group - is the global market leader in specialty chemicals. Our business is creating essentials - innovative products and system solutions that make indispensable contributions to our customers’ success. In fiscal 2006 around 36,000 employees worldwide generated sales of 10.9 billion euros and operating profits (EBIT) of more than 870 million euros.

Back to overview.
Imprint Copyright Privacy Statement Disclaimer